DA Davidson raised the firm’s price target on Standex (SXI) to $219 from $200 and keeps a Buy rating on the shares after its Q4 earnings beat. After nearly two straight years of organic declines each quarter, Standex appears to be on the verge of finally breaking that streak, with a mix of organic and acquired revenue growth, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SXI: